This statistic displays the top ten oncology products worldwide in 2018, ranked by revenue. The second product on this list is Opdivo , a cancer drug from Bristol-Myers Squibb/Ono. Opdivo is a prescription medication used in the treatment of patients with advanced stage lung cancer.
Top cancer drugs based on revenue worldwide 2018
Top 10 cancer drugs worldwide by revenue in 2018
(in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Average prices of Gleevec - selected countries 2013
- Revenue as a part of R&D spending for select cancer drugs 2017
- Revenue since approval for select cancer drugs 2017
- Number of clinical trials in Italy 2018, by type of drug
- Number of new cancer pharmaceuticals approved by EMA in Sweden 2014-2017
- Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
- Expensive cancer drugs by annual Medicare payments in the U.S. 2014
- Public expenditure on innovative drugs in Italy 2015-2018
- Italy: consumption of cancer drugs 2017, by region
- Public expenditure on the most prescribed drugs in Italy 2018, by category
- Metastatic cancer treatment market worldwide 2017 and 2025
- Number of clinical trials for rare diseases in Italy 2018, by funding institution
- Number of clinical trials for rare diseases in Italy 2018, by type of drug
- Unsuccessful developing lung cancer drugs in the U.S. 1998-2014
- Unsuccessful developing melanoma drugs in the U.S. 1998-2014
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Cancer drugs on the world market 2010
- Percentage of Rx drugs prescribed to multiple sclerosis patients 2013
- Monthly value of blood imports into Iceland 2018
- Length of longest beaches globally
Further related statistics
Genetic Engineering & Biotechnology News. (April 22, 2019). Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 10, 2019, from https://www.statista.com/statistics/288538/top-cancer-drugs-based-on-revenue/
Genetic Engineering & Biotechnology News. "Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)." Chart. April 22, 2019. Statista. Accessed December 10, 2019. https://www.statista.com/statistics/288538/top-cancer-drugs-based-on-revenue/
Genetic Engineering & Biotechnology News. (2019). Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 10, 2019. https://www.statista.com/statistics/288538/top-cancer-drugs-based-on-revenue/
Genetic Engineering & Biotechnology News. "Top 10 Cancer Drugs Worldwide by Revenue in 2018 (in Billion U.S. Dollars)." Statista, Statista Inc., 22 Apr 2019, https://www.statista.com/statistics/288538/top-cancer-drugs-based-on-revenue/
Genetic Engineering & Biotechnology News, Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/288538/top-cancer-drugs-based-on-revenue/ (last visited December 10, 2019)